Side-by-side comparison of AI visibility scores, market position, and capabilities
St. Petersburg FL contract electronics manufacturing (NYSE: JBL) ~$28.9B FY2024 revenue; $500M US AI data center manufacturing investment, hyperscaler and Apple primary EMS competing with Foxconn and Flex.
Jabil Inc. is a St. Petersburg, Florida-based contract electronics manufacturing services (EMS) and supply chain solutions company — publicly traded on the New York Stock Exchange (NYSE: JBL) as an S&P 500 Information Technology component — providing design, manufacturing, testing, and supply chain management services for electronics and manufactured products across cloud and digital commerce infrastructure, healthcare, automotive, industrial, and consumer markets through approximately 100,000 employees in 100+ facilities across 30+ countries. Jabil is one of the three largest global EMS providers, competing directly with Foxconn (Hon Hai) and Flex Ltd for multinational OEM manufacturing outsourcing. In fiscal year 2024 (ending August 2024), Jabil reported revenue of approximately $28.9 billion after completing the divestiture of its Healthcare segment (sold to a consortium led by PE firm CD&R for approximately $950 million in 2024), which represented a strategic decision to concentrate on higher-growth EMS segments. Jabil's $500 million announced investment in Southeast United States manufacturing for AI data center infrastructure customers — targeting hyperscale data center compute, networking, and storage hardware — is expected to be operational by mid-2026. CEO Mike Dastoor assumed leadership in 2024 following Mark Mondello's retirement, prioritizing AI infrastructure manufacturing as the primary growth vector.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.